Patent Assignment
Reel/Frame 026571/0616
Release of Security Interest Recorded at Reel/Frame 25434/842
Recorded: 2011-07-11
Pages: 8
Assignor
JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
Executed: 2011-06-17
Assignee
ENDO PHARMACEUTICALS SOLUTIONS INC.
100 ENDO BLVD., CHADDS FORD, PENNSYLVANIA, 19317
Covered Properties
(38)
Platelet Activating Factor Antagonist and Methods of Use Therefor
Patent:
4,973,603 →
Application:
07/350,391 →
Preparation of Homogeneous Hydrogel Copolymers
Patent:
5,266,325 →
Application:
07/621,346 →
Manufacture of Water-Swellable Hydrophilic Articles and Drug Delivery Devices
Patent:
5,292,515 →
Application:
08/041,523 →
Compound for Inhibiting Hiv Infectivity
Patent:
5,614,559 →
Application:
08/245,619 →
Efficient Method to Conduct Large-Scale Genome Sequencing
Patent:
5,670,321 →
Application:
08/438,567 →
Compound for Inhibiting Hiv Infectivity
Patent:
5,677,343 →
Application:
08/467,725 →
Compound for Inhibiting Hiv Infectivity
Patent:
6,075,050 →
Application:
08/467,728 →
Sulfonic Acid and Aldehyde Condensation Polymers for Preventing Pregnancy
Patent:
5,958,399 →
Application:
08/847,019 →
Compound for Inhibiting Hiv Infectivity
Patent:
6,365,625 →
Application:
09/398,571 →
Methods and Compositions for Alleviating Stuttering
Patent:
6,855,721 →
Application:
09/628,803 →
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
Patent:
6,361,797 →
Application:
09/646,066 →
Methods of Treating Obsessive-Compulsive Disorder
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone
Implanting Device and Method of Using Same
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Methods and Compositions for Alleviating Stuttering
Compositions and Methods for Treating Precocious Puberty
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2OXO-Hexyl)-1-Isoidolinone
Use of Pagoclone for the Treatment of Social Anxiety Disorder
Controlled Release Formulations of Octreotide
Method for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone)
Method of Inserting an Object Under the Skin
Implant Device Release Agents and Methods of Using Same
Delivery of Dry Formulations of Octreotide
Controlled Release Formulations of Octreotide
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Compositions and Methods for the Treatment of Bladder Cancer
Application:
12/324,019 →
Publication:
US 2009/0214634
Implantable Device for the Delivery of Naltrexone and Methods of Use Thereof
Application:
12/351,617 →
Publication:
US 2009/0208540
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Combination Treatment for Bladder Cancer
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
An Implantable Device for the Sustained Release of a Polypeptide
Octreotide Implant Having a Release Agent and Uses Thereof
Implantable Device for the Delivery of Risperidone and Methods of Use Thereof
Controlled Release Formulations of Octreotide
Application:
12/814,276 →
Publication:
US 2011/0009338
Controlled Release Formulations of Octreotide
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Implanting Device
Patent:
492,995 →
Application:
29/179,382 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 7, 2004
From: WARNER LAMBERT COMPANY LLC (FORMERLY KNOWN AS WARNER LAMBERT COMPANY)
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 014608/0212 →
Assignment of Assignor's Interest
May 7, 2004
From: WARNER LAMBERT COMPANY, LLC (FORMERLY KNOWN AS WARNER LAMBERT COMPANY)
To: INDEVUS PHARMACEUTICALS INC.
Reel/Frame 014608/0196 →
Assignment of Assignor's Interest
May 7, 2004
From: WARNER LAMBERT COMPANY LLC (FORMERLY KNOWN AS WARNER LAMBER COMPANY)
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 014608/0181 →
Corrective Assignment to Correct the Serial No. on Recordation Cover Sheet Was Incorrectly Identified Previously Recorded on Reel 016618 Frame 0548. Assignor(S) Hereby Confirms the Assignment of Serial No. 11/155,822.
Dec 5, 2005
From: KUZMA, PETR
To: VALERA PHARMACEUTICALS, INC.
Reel/Frame 016850/0492 →
Assignment of Assignor's Interest
Apr 27, 2006
From: WARNER LAMBERT COMPANY LLC (FORMERLY KNOWN AS WARNER-LAMBERT COMPANY)
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019931/0393 →
Assignment of Assignor's Interest
Apr 27, 2006
From: JENNINGS, SANDRA MARIE; STUK, TIMOTHY LEE
To: WARNER-LAMBERT COMPANY
Reel/Frame 017834/0508 →
Assignment of Assignor's Interest
May 31, 2006
From: KUZMA, PETR; DECKER, STEPHANIE
To: VALERA PHARMACEUTICALS, INC.
Reel/Frame 017695/0010 →
Assignment of Assignor's Interest
Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0605 →
Assignment of Assignor's Interest
Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0317 →
Assignment of Assignor's Interest
Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0464 →
Assignment of Assignor's Interest
Sep 11, 2007
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 019805/0475 →
Assignment of Assignor's Interest
Jan 9, 2008
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 020342/0595 →
Merger
Jan 23, 2008
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 020404/0071 →
Corrective Assignment to Correct the Patent Number, Serial Number, Filing Date, and Issue Date. Previously Recorded on Reel 022151 Frame 0332. Assignor(S) Hereby Confirms the Please Change Patent No. from "6,670,320" to --5,670,321--..
Jan 28, 2009
From: PROGENITOR, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 022162/0207 →
Change of Name
Oct 2, 2009
From: INDEVUS PHARMACEUTICALS INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 023312/0681 →
Security Agreement
Oct 19, 2009
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023390/0220 →
Security Agreement
Dec 1, 2010
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025434/0842 →
Release of Patent Security Interest Recorded at Reel/Frame 23390/220
Dec 3, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 025441/0710 →
Security Agreement
Jul 7, 2011
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026557/0373 →
Change of Name
Feb 27, 2014
From: PROCEPT, INC.
To: HEAVENLYDOOR.COM, INC.
Reel/Frame 032366/0915 →
Merger and Change of Name
Feb 27, 2014
From: HEAVENLYDOOR.COM, INC.
To: PALIGENT INC.
Reel/Frame 032366/0904 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0226 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Assignment of Assignor's Interest
Nov 19, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: BRAEBURN PHARMACEUTICALS BVBA SPRL
Reel/Frame 034206/0253 →
Assignment of Assignor's Interest
Jun 3, 2016
From: BRAEBURN PHARMACEUTICALS BVBA SPRL
To: BRAEBURN PHARMACEUTICALS, INC.
Reel/Frame 038800/0527 →